Eltrombopag

Таблетки By prescription

Eltrombopag is a medication used to treat thrombocytopenia and severe aplastic anaemia.

Eltrombopag

Indications

The drug Eltrombopag is used to treat adults, adolescents and children aged 3 years and older.

- treatment of patients aged 3 years and older with a blood disorder in which the body's own immune system attacks and destroys blood platelets (immune thrombocytopenia) that has lasted 6 months or more from the time of diagnosis and in whom there has been insufficient improvement from previous treatment (e.g. corticosteroids or immunoglobulins) to reduce the risk of bleeding.

- Treatment of patients aged 18 years and older with viral liver inflammation (chronic viral hepatitis C) to enable antiviral treatment or to improve ongoing antiviral treatment including interferon drugs.

- treatment of patients aged 3 years and older with a condition where the bone marrow is capable of producing too few blood cells (severe aplastic anaemia) as part of the very first treatment attempt (first-line therapy) in conjunction with immune suppressive drugs (standard immunosuppressive therapy).

treatment of patients aged 18 years and older with severe aplastic anaemia who have not improved sufficiently with immune suppressive therapy (immunosuppressive therapy).

Contraindications

Do not take Eltrombopag if you (your child):

- Allergic to Eltrombopag or to any other ingredients of this medicine (listed in section 6 of the leaflet).

- if you have been diagnosed with a type of blood cancer in which immature blood cells in the bone marrow do not mature and are therefore unable to fulfil their functions (myelodysplastic syndrome - MDS) - due to a lack of efficacy and safety data.

- pregnancy or you are breastfeeding your child.

This dosage form is not intended for children under 3 years of age.

Usage

Inside, the dose and dosage regimen are selected individually.

Download full instruction

Report undesirable reaction

If you have information about undesirable reaction after taking the drug

Hotline +7 (495) 984-28-47

Report

Have questions? Contact Us

Has contraindications. Needs specialist overview.

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.